|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
PRAVASTATIN AND FENOFIBRATE |
C10BA03 |
RO
|
Not authorised
|
07-02-2024 |
|
|
VALID
|
|
SIMVASTATIN AND FENOFIBRATE |
C10BA04 |
RO
|
Not authorised
|
07-02-2024 |
|
|
VALID
|
|
CONJUGATED ESTROGENS AND BAZEDOXIFENE |
G03CC07 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
PREDNISOLONE |
H02AB06 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
PROMESTRIENE |
G03CA09 |
RO
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
CYPROTERONE |
G03HA01 |
RO
|
I
|
22-02-2024 |
|
|
VALID
|
|
ESTRADIOL |
G03CA03 |
RO
|
II
|
22-02-2024 |
|
|
VALID
|
|
TERLIPRESSIN |
H01BA04 |
RO
|
I
|
22-02-2024 |
|
|
VALID
|
|
TIBOLONE |
G03CX01 |
RO
|
I
|
22-02-2024 |
|
|
VALID
|
|
NICOTINIC ACID, COMBINATIONS |
C10AD52 |
RO
|
Not authorised
|
18-04-2024 |
|
|
VALID
|
|
ADAGRASIB |
L01XX77 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
ELRANATAMAB |
L01FX32 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
ETRASIMOD |
L04AE05 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
RO
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
FEZOLINETANT |
G02CX06 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
GLYCERYL TRINITRATE |
C01DA02 |
RO
|
I
|
29-07-2024 |
3846 |
20-10-2003 |
VALID
|
|
GLUCAGON |
H04AA01 |
RO
|
I
|
01-08-2024 |
2816 |
04-09-2002 |
VALID
|
|
DROTAVERINE |
A03AD02 |
RO
|
I + Exemption
|
13-08-2024 |
3609 |
11-07-2003 |
VALID
|
|
EPINEPHRINE |
C01CA24 |
RO
|
I
|
13-08-2024 |
1652 |
|
VALID
|
|
PRAVASTATIN |
C10AA03 |
RO
|
Not authorised
|
03-12-2024 |
3691 |
12-08-2003 |
VALID
|
|
ATORVASTATIN |
C10AA05 |
RO
|
II
|
04-12-2024 |
3515 |
16-06-2003 |
VALID
|
|
FLUVASTATIN |
C10AA04 |
RO
|
II
|
04-12-2024 |
3020 |
31-12-2002 |
VALID
|
|
GEMFIBROZIL |
C10AB04 |
RO
|
Not authorised
|
04-12-2024 |
225 |
29-09-1999 |
VALID
|
|
LOVASTATIN |
C10AA02 |
RO
|
II
|
04-12-2024 |
3621 |
15-07-2003 |
VALID
|
|
ROSUVASTATIN |
C10AA07 |
RO
|
II
|
04-12-2024 |
RO/H/0105/002/II/005 |
03-06-2013 |
VALID
|
|
SIMVASTATIN |
C10AA01 |
RO
|
II
|
04-12-2024 |
|
|
VALID
|
|
CIPROFIBRATE |
C10AB08 |
RO
|
Not authorised
|
05-12-2024 |
|
|
VALID
|
|
COLESEVELAM |
C10AC04 |
RO
|
Not authorised
|
05-12-2024 |
|
|
VALID
|
|
FENOFIBRATE |
C10AB05 |
RO
|
II
|
05-12-2024 |
4085 |
29-12-2003 |
VALID
|
|
ACIPIMOX |
C10AD06 |
RO
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
PROBUCOL |
C10AX02 |
RO
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
ALIROCUMAB |
C10AX14 |
RO
|
I
|
09-12-2024 |
EMEA/H/C/003882 |
23-09-2015 |
VALID
|
|
BEMPEDOIC ACID |
C10AX15 |
RO
|
Not authorised
|
09-12-2024 |
EMEA/H/C/004958 |
01-04-2020 |
VALID
|
|
EVOLOCUMAB |
C10AX13 |
RO
|
I
|
09-12-2024 |
|
|
VALID
|
|
LOMITAPIDE |
C10AX12 |
RO
|
POM
|
09-12-2024 |
|
|
VALID
|
|
BEMPEDOIC ACID AND EZETIMIBE |
C10BA10 |
RO
|
Not subject to prescription - Supply through general sales
|
10-12-2024 |
EMEA/H/C/004959 |
27-03-2020 |
VALID
|
|
ROSUVASTATIN AND EZETIMIBE |
C10BA06 |
RO
|
II
|
10-12-2024 |
|
|
VALID
|